XML 22 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Noncontrolling Interests (Tables)
 3 Months Ended
Mar. 31, 2014
Notes to Financial Statements [Abstract]  
Net equity balance of noncontrolling interests
The net equity balance of the noncontrolling interests as of March 31, 2014 and December 31, 2013 included the following:
 
2014
 
2013
Non-redeemable noncontrolling interests:
 
 
 
Noncontrolling interests in consolidated joint ventures
$
(13,424
)
 
$
(37,191
)
Noncontrolling interests in partnership equity of TRG
74,282

 
(58,342
)
 
$
60,858

 
$
(95,533
)
Net income (loss) attributable to noncontrolling interests
Net income attributable to the noncontrolling interests for the three months ended March 31, 2014 and March 31, 2013 included the following:
 
2014
 
2013
Net income attributable to noncontrolling interests:
 
 
 
Non-redeemable noncontrolling interests:
 
 
 
Noncontrolling share of income of consolidated joint ventures
$
3,118

 
$
2,782

Noncontrolling share of income of TRG
147,662

 
11,788

 
$
150,780

 
$
14,570
Effects of changes in ownership interest in consolidated subsidiaries on equity
The following schedule presents the effects of changes in Taubman Centers, Inc.’s ownership interest in consolidated subsidiaries on Taubman Centers, Inc.’s equity for the three months ended March 31, 2014 and March 31, 2013:
 
2014
 
2013
Net income attributable to Taubman Centers, Inc. common shareowners
$
369,125

 
$
27,744

Transfers (to) from the noncontrolling interest –
 

 
 

Decrease in Taubman Centers, Inc.’s paid-in capital for adjustments of noncontrolling interest (1)
(6
)
 
(55
)
Net transfers (to) from noncontrolling interests
(6
)
 
(55
)
Change from net income attributable to Taubman Centers, Inc. and transfers (to) from noncontrolling interests
$
369,119

 
$
27,689


(1)
In 2014 and 2013, adjustments of noncontrolling interests were made as a result of changes in the Company's ownership of the Operating Partnership in connection with the Company's share-based compensation under employee and director benefit plans (Note 9), issuances of stock pursuant to the Continuing Offer (Note 10), and stock repurchases (Note 6)